Tags
- 3000
- 4
- 5-HT1A receptor
- 5-HT2A receptor
- 5-HT2B receptor
- 5-HT6 receptor
- 5-HT7 receptor
- 5-HT receptor
- A
- Acid
- Acts
- Acute
- Addiction
- Addictive
- Address space
- ADHD
- Adjunct
- Administration
- Adrenergic
- Adrenergic receptor
- Adult
- Adverse
- Adverse effect
- Agent
- Agonist
- AIM
- Aims
- Alpha-1A adrenergic receptor
- Alphabetical order
- AMPA
- AMPA receptor
- An
- Analysis
- Antagonist
- Antagonize
- Antidepressant
- Antidepressant effects
- Antipsychotic
- Anxiety
- Anxiety disorder
- Appropriation
- Approval
- Ashley Meyer
- Assesse
- Attention
- Attention Deficit
- Attention deficit hyperactivity disorder
- Augment
- Author
- Authors
- Awaiting
- Ba
- Barrier
- BBB
- Being
- Benefit
- Benefits
- Bhumika Patel
- Bipolar
- Bipolar disorder
- Bipolar Disorders
- Blocking
- Blood
- Blood–brain barrier
- Blood pressure
- Brain
- Brazil
- BS
- California
- Candidate
- Cause
- Cedars-Sinai Medical Center
- Cerebrospinal fluid
- Characteristic
- Chemical synapse
- Cleft
- CLIN
- Clinic
- Clinical
- Clinical neuroscience
- Clinical trial
- Clinical Trials
- Clinician
- Cognition
- Cognitive
- Cognitive benefits
- Cognitive improvement
- Combination therapy
- Combining
- Common side effects
- Comparison
- Comprehensive
- Compulsive behavior
- Conclusion
- Conducting
- Conflict
- Conflicts of Interest
- Consensus
- Containment
- Content
- contributing
- Convention
- Cortex
- Cross
- Crucial
- CYP
- Cytochrome
- Cytochrome P450
- D2
- D3
- D4
- Data
- Database
- David Geffen
- David Geffen School of Medicine at UCLA
- Deficit
- Demonstrate
- Demonstration
- Depression
- Depressive
- Described
- Detail
- Determine
- Development
- Diagnosis
- Diagnostic and Statistical Manual of Mental Disorders
- Disclosed
- Disorder
- Distinct
- Dizziness
- Dopamine
- Dopamine receptor D2
- Dopaminergic
- Dosage
- Dose
- Dosing
- DR
- Drew Hirsch
- Drs Totlani
- Drug
- Drug interaction
- Dry
- DSM-5
- Duration
- Dysfunction
- Eating disorder
- EEG
- Effect
- Efficacy
- EKG
- Electrocardiography
- Electroencephalography
- Emerging
- Enhance
- Enhancement
- Enzyme
- Establishment
- Estrogen
- Estrogen receptor
- Estrogen receptor modulator
- Evaluation
- Evidence
- Excretion
- Executive
- Extracted
- Extrapyramidal
- Extrapyramidal symptoms
- FDA
- Fda-approved
- Five
- Fluid
- Food
- Food and Drug Administration
- Formulation
- Freire
- Full-text search
- Functional selectivity
- Gain
- Geffen
- Generic
- Glutamatergic
- Glycine
- Glycine transporter
- Glycine transporter 1
- Goal
- Group action
- Health
- Health system
- Hedrick
- Hirsch
- Hundred
- Identified
- Impact
- Include
- Indiana State Road 25
- Indication
- Information Technology Act, 2000
- Inhibitor
- Injection
- Innovation
- Innovations
- In-phase and quadrature components
- Insight
- Insights
- Interaction
- Interactions
- Investigation
- Involve
- Irvine, California
- Ishak Md
- Ishak Murphy
- J
- J. Alexander
- Jayant Totlani
- Jennifer Haigh
- Keyword
- Khan
- Kim Hedrick
- Kim Md
- Known
- Lack
- Levels
- Linguistics
- Lipid
- Lithium
- Loma Lina
- Loma Linda
- Loma Linda University
- Long term
- Long-term effect
- Long-term effects
- Los Angeles
- Lower risk
- Lucy Prebble
- Luiza Freire
- Lumateperone
- Magic: The Gathering core sets, 1993–2007
- Maintaining
- Manual
- Marked
- M.D.
- Mechanism
- Mechanism of action
- Medication
- Medicine
- Memory
- Memory performance
- Menopause
- Mental
- Mental disorder
- Mental health
- Metabolism
- Metabolite
- Methods
- Meyer Bs
- Milligram
- MIN-101
- Minimal impact
- Minimisation
- Modified-release dosage
- Modulator
- Mohamed Salem
- Mood disorder
- Most
- Multimodal
- Murphy Md
- Murphy Renteria
- Muscarinic acetylcholine receptor
- Muscarinic agonist
- Muscarinic antagonist
- N
- Nathalie Murphy
- Nausea
- Negative
- Negligible
- Neural
- Neural development
- Neurocognitive
- Neurocognitive disorders
- Neurodevelopmental disorder
- Neuroscience
- New
- Nine
- NMDA receptor
- N-Methyl-D-aspartic acid
- No
- Nomenclature
- Note
- Noted
- Obligatio consensu
- Obsession
- Obsessive–compulsive disorder
- Occupancy
- OCD
- Of June
- Olanzapine
- Only
- Option
- Options
- Oral administration
- Organ
- Organized
- Outline of health sciences
- Over
- Overview
- Parameters
- Parrish Bs
- Partial
- Partial agonist
- Participation
- Pathways
- Patient
- Paul Sydow
- Pe Brazil
- Pediatrics
- Pediatric use
- Performance
- Peripheral
- Pharmaceutical drug
- Pharmacology
- Pharmacovigilance
- Phase
- Phase 1
- Phase II
- Phase III
- Phases
- Phases of clinical research
- PHD
- Pipeline
- Placebo
- Plasticity
- PLU
- Pomona
- Pomona, California
- Population
- Positive
- Positive and Negative Syndrome Scale
- Postmenopausal women
- Post-traumatic
- Posttraumatic stress disorder
- Potent
- Potential benefits
- Prefrontal cortex
- Pressure
- Profile
- Profiles
- Prolactin
- Promise
- Promising
- Protocols
- Psychiatric medication
- Psychiatry
- Psychosis
- Psychotic symptom
- Psychotic symptoms
- PTSD
- Publishing
- PubMed
- R1
- Rangefinder
- Rasha Abdelsalam
- Rebecca Hedrick
- Receptor
- Receptor activity
- Receptor modulator
- Receptor occupancy
- Reduce
- Reducing
- Reduction
- Regulation
- Renteria
- Require
- Result
- Rida Khan
- Risk
- Route
- RP-5063
- Ryan Brown
- Sabrina Renteria
- Safety
- Salem Bs
- Sarah Kim
- Saúde
- Scale
- Schizophrenia
- School
- School of Medicine
- Science
- Score
- Searched
- Sedation
- Selected
- Serotonergic
- Serotonin
- Sexual
- Sexual dysfunction
- Sexual dysfunctions
- Shown
- Side Effects
- Signaling
- Sleep-wake disorders
- Somnolence
- Specific
- Stable
- Stages of development
- Statistics
- Steiner
- Still
- Stimulation
- Stress
- Studie
- Study duration
- Subcutaneous
- Subcutaneous injection
- Summary
- Symptom
- Symptoms
- Synaptic
- Synaptic plasticity
- Synchrony
- Syndrome
- Systematic
- Systematic review
- TAAR1
- Table
- Tables
- Target
- Targeting
- Targets
- Tested
- Text
- The brain
- The Mechanism
- Therapy
- The Transporter
- Thoma
- Thomas Chandy
- Thomas Parrish
- Three
- Tiffany Chang
- Tolerance
- Total
- Trace amine-associated receptor
- Tract
- Transporter
- Treat
- Treating
- Treatment options
- Trial
- Trials
- Trospium chloride
- Twin Cinema
- UCLA
- United State
- University
- University of California
- University of California, Irvine
- University of California, Irvine School of Medicine
- University of Health Sciences
- Until June
- Urine
- Usability
- Valproate
- Via
- Volunteer
- Volunteers
- Weight
- Weight gain
- Western
- Western University
- Western University of Health Sciences
- William Ishak
- Women
- Working memory
- Xanomeline